Jens Packeisen
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Tumors and Oncological Cases, Estrogen and related hormone effects, Gene expression and cancer classification
Most-Cited Works
- → Cytogenetic Alterations and Cytokeratin Expression Patterns in Breast Cancer: Integrating a New Model of Breast Differentiation into Cytogenetic Pathways of Breast Carcinogenesis(2002)244 cited
- → The origin of vimentin expression in invasive breast cancer: epithelial–mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?(2005)228 cited
- → Poorly Differentiated Breast Carcinoma is Associated with Increased Expression of the Human Polycomb Group EZH2 Gene(2003)195 cited
- → Demystified … Tissue microarray technology(2003)144 cited
- → Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity(2006)142 cited
- → Interlaboratory variability of Ki67 staining in breast cancer(2017)99 cited
- → First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor‐positive breast cancer(2005)96 cited
- → Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence—first results of an inter‐ethnic breast cancer study(2004)92 cited
- → Tissue microarrays: a new approach for quality control in immunohistochemistry(2002)88 cited
- → Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression(2005)81 cited